Besides, significant differences between high‐risk PCa patients [Gleason score (GS) ≥ 8] and low‐ or medium‐risk PCa patients (GS ≤ 6 or =7) were detected in all these 3 genes (P = 8.5 × 10−6 and 5.0 × 10−3 for HNRNPA2B1 and MAPK8IP3 in GS ≥ 8 vs GS ≤ 6, respectively. The gene discussed is MAPK8IP3; the disease is posterior cortical atrophy.